BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27481063)

  • 1. Succinyl-5-aminoimidazole-4-carboxamide-1-ribose 5'-Phosphate (SAICAR) Activates Pyruvate Kinase Isoform M2 (PKM2) in Its Dimeric Form.
    Yan M; Chakravarthy S; Tokuda JM; Pollack L; Bowman GD; Lee YS
    Biochemistry; 2016 Aug; 55(33):4731-6. PubMed ID: 27481063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells.
    Keller KE; Doctor ZM; Dwyer ZW; Lee YS
    Mol Cell; 2014 Mar; 53(5):700-9. PubMed ID: 24606918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions.
    Keller KE; Tan IS; Lee YS
    Science; 2012 Nov; 338(6110):1069-72. PubMed ID: 23086999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAICAR binding activates PKM2 protein kinase activity.
    Cancer Discov; 2014 May; 4(5):OF20. PubMed ID: 24795025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native Mass Spectrometry Gives Insight into the Allosteric Binding Mechanism of M2 Pyruvate Kinase to Fructose-1,6-Bisphosphate.
    Gavriilidou AFM; Holding FP; Mayer D; Coyle JE; Veprintsev DB; Zenobi R
    Biochemistry; 2018 Mar; 57(11):1685-1689. PubMed ID: 29499117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Investigation of a Dimeric Variant of Pyruvate Kinase Muscle Isoform 2.
    Srivastava D; Razzaghi M; Henzl MT; Dey M
    Biochemistry; 2017 Dec; 56(50):6517-6520. PubMed ID: 29182273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for allosteric regulation of pyruvate kinase M2 by phosphorylation and acetylation.
    Nandi S; Razzaghi M; Srivastava D; Dey M
    J Biol Chem; 2020 Dec; 295(51):17425-17440. PubMed ID: 33453989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.
    Anastasiou D; Yu Y; Israelsen WJ; Jiang JK; Boxer MB; Hong BS; Tempel W; Dimov S; Shen M; Jha A; Yang H; Mattaini KR; Metallo CM; Fiske BP; Courtney KD; Malstrom S; Khan TM; Kung C; Skoumbourdis AP; Veith H; Southall N; Walsh MJ; Brimacombe KR; Leister W; Lunt SY; Johnson ZR; Yen KE; Kunii K; Davidson SM; Christofk HR; Austin CP; Inglese J; Harris MH; Asara JM; Stephanopoulos G; Salituro FG; Jin S; Dang L; Auld DS; Park HW; Cantley LC; Thomas CJ; Vander Heiden MG
    Nat Chem Biol; 2012 Oct; 8(10):839-47. PubMed ID: 22922757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.
    Pan Y; Wang W; Huang S; Ni W; Wei Z; Cao Y; Yu S; Jia Q; Wu Y; Chai C; Zheng Q; Zhang L; Wang A; Sun Z; Huang S; Wang S; Chen W; Lu Y
    J Cell Mol Med; 2019 Oct; 23(10):6846-6858. PubMed ID: 31343107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.
    Gao X; Wang H; Yang JJ; Liu X; Liu ZR
    Mol Cell; 2012 Mar; 45(5):598-609. PubMed ID: 22306293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal regulation of protein kinase and pyruvate kinase activities of pyruvate kinase M2 by growth signals.
    Gao X; Wang H; Yang JJ; Chen J; Jie J; Li L; Zhang Y; Liu ZR
    J Biol Chem; 2013 May; 288(22):15971-9. PubMed ID: 23576436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycolytic reprogramming in cancer cells: PKM2 dimer predominance induced by pulsatile PFK-1 activity.
    Shi X; You L; Luo RY
    Phys Biol; 2019 Sep; 16(6):066007. PubMed ID: 31469100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular association of glucose-6-phosphate isomerase and pyruvate kinase M2 with glyceraldehyde-3-phosphate dehydrogenase in cancer cells.
    Das MR; Bag AK; Saha S; Ghosh A; Dey SK; Das P; Mandal C; Ray S; Chakrabarti S; Ray M; Jana SS
    BMC Cancer; 2016 Feb; 16():152. PubMed ID: 26911935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic and Structural Insights into Cysteine-Mediated Inhibition of Pyruvate Kinase Muscle Isoform 2.
    Srivastava D; Nandi S; Dey M
    Biochemistry; 2019 Sep; 58(35):3669-3682. PubMed ID: 31386812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Please keep me 2uned to PKM2.
    McKnight SL
    Mol Cell; 2014 Mar; 53(5):683-4. PubMed ID: 24606916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase.
    Mor I; Carlessi R; Ast T; Feinstein E; Kimchi A
    Oncogene; 2012 Feb; 31(6):683-93. PubMed ID: 21725354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of PKM2 in cancer progression and its structural and biological basis.
    Wu B; Liang Z; Lan H; Teng X; Wang C
    J Physiol Biochem; 2024 May; 80(2):261-275. PubMed ID: 38329688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
    Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
    Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Allosteric Mechanism of Fructose-1,6-bisphosphate and Serine for Pyruvate Kinase M2 via Dynamics Fluctuation Network Analysis.
    Yang J; Liu H; Liu X; Gu C; Luo R; Chen HF
    J Chem Inf Model; 2016 Jun; 56(6):1184-1192. PubMed ID: 27227511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
    Mazurek S
    Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.